Related Experiment Videos
Hepatitis C virus genotypes in chronic dialysis patients
F Fabrizi1, G Lunghi, I Guarnori
1Nephrology Department, Hospital of Lecco, Italy.
Summary
Hepatitis C virus (HCV) subtype 2a is dominant in dialysis patients. Antibody response to NS4 proteins was less frequent in genotype 2a carriers, suggesting potential interferon therapy response and nosocomial transmission.
Area of Science:
- Hepatology
- Virology
- Nephrology
Background:
- Hepatitis C virus (HCV) infection is common in dialysis patients.
- This study aimed to characterize HCV genotypes in this population.
- 55 anti-HCV-positive patients undergoing chronic dialysis were analyzed.
Purpose of the Study:
- To determine the distribution of HCV genotypes in dialysis patients.
- To investigate associations between HCV genotype and patient characteristics.
- To explore genotype-specific antibody responses and implications for therapy.
Main Methods:
- HCV RNA detection using reverse transcription polymerase chain reaction (RT-PCR).
- HCV genotyping via hybridization with type-specific oligonucleotide probes.
- Analysis of demographic and clinical features, and antibody responses to NS4 proteins.
Main Results:
- HCV subtype 2a was the most prevalent (56%), followed by 1b (31%).
- No significant association was found between HCV genotype and patient demographics or clinical features.
- Antibody response to NS4 proteins was less frequent in genotype 2a carriers compared to genotype 1b carriers (p=0.004).
Conclusions:
- HCV subtype 2a is dominant in anti-HCV-positive dialysis patients.
- Absence of NS4 antibody response in genotype 2a carriers may predict interferon therapy response.
- Viral population homogeneity suggests potential nosocomial transmission within the dialysis unit.